BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33825929)

  • 21. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group.
    Cho J; Ahn H; Hwang SI; Lee HJ; Choe G; Byun SS; Hong SK
    Prostate Int; 2020 Dec; 8(4):146-151. PubMed ID: 33425791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric magnetic resonance imaging-based assessment of the effect of adenomyosis on determining the depth of myometrial invasion in endometrial cancer.
    Meng X; Liu M; Yang D; Jin H; Liu Y; Xu H; Liang Y; Wang Z; Wang L; Yang Z
    Quant Imaging Med Surg; 2024 May; 14(5):3717-3730. PubMed ID: 38720853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of the value of dynamic contrast enhanced (DCE) imaging for prostate cancer detection, with pathology correlation.
    Al Salmi I; Menezes T; El-Khodary M; Monteiro S; Haider EA; Alabousi A
    Can J Urol; 2020 Jun; 27(3):10220-10227. PubMed ID: 32544044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
    Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
    Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS.
    Noh TI; Shim JS; Kang SG; Sung DJ; Cheon J; Sim KC; Kang SH
    Sci Rep; 2022 Nov; 12(1):20689. PubMed ID: 36450813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving reader accuracy and specificity with the addition of hybrid multidimensional-MRI to multiparametric-MRI in diagnosing clinically significant prostate cancers.
    Lee G; Chatterjee A; Harmath C; Karademir I; Engelmann R; Yousuf A; Islam S; Karczmar G; Oto A; Giurcanu M; Antic T; Eggener S
    Abdom Radiol (NY); 2023 Oct; 48(10):3216-3228. PubMed ID: 37358605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
    Choi MH; Kim CK; Lee YJ; Jung SE
    AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
    Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
    BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
    Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
    Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer.
    Cereser L; Giannarini G; Bonato F; Pizzolitto S; Como G; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
    Minerva Urol Nephrol; 2022 Feb; 74(1):29-37. PubMed ID: 33016030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.
    Lin G; Huang YT; Chao A; Lin YC; Yang LY; Wu RC; Lu HY; Ng SH; Ng KK; Lai CH
    Eur Radiol; 2017 May; 27(5):1867-1876. PubMed ID: 27631107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort.
    Verbakel JY; Mascilini F; Wynants L; Fischerova D; Testa AC; Franchi D; Frühauf F; Cibula D; Lindqvist PG; Fruscio R; Haak LA; Opolskiene G; Alcazar JL; Mais V; Carlson JW; Sladkevicius P; Timmerman D; Valentin L; Bosch TVD; Epstein E
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):115-124. PubMed ID: 31225683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Woo S; Suh CH; Kim SY; Cho JY; Kim SH; Moon MH
    AJR Am J Roentgenol; 2018 Nov; 211(5):W226-W241. PubMed ID: 30240296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Magnetic Resonance Volumetry in Predicting Myometrial Invasion, Lymphovascular Space Invasion, and Tumor Grade: Is It Valuable in International Federation of Gynecology and Obstetrics Stage I Endometrial Cancer?
    Sahin H; Sarioglu FC; Bagci M; Karadeniz T; Uluer H; Sanci M
    Int J Gynecol Cancer; 2018 May; 28(4):666-674. PubMed ID: 29697491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biparametric
    Scialpi M; Prosperi E; D'Andrea A; Martorana E; Malaspina C; Palumbo B; Orlandi A; Falcone G; Milizia M; Mearini L; Aisa MC; Scialpi P; DE Dominicis C; Bianchi G; Sidoni A
    Anticancer Res; 2017 Mar; 37(3):1263-1271. PubMed ID: 28314291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L; Chen Y; Xu H; Xie H; Yao J; Liu J; Song B
    Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J; Garstka N; Helbich TH; Shariat SF; Baltzer PA
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Round table: arguments against using multiparametric prostate MRI protocols.
    Ward R; Purysko AS
    Abdom Radiol (NY); 2020 Dec; 45(12):3997-4002. PubMed ID: 32140766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
    Giannarini G; Cereser L; Como G; Bonato F; Pizzolitto S; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
    Acta Radiol; 2021 Jul; 62(7):949-958. PubMed ID: 32718179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.